位置:首页 > 蛋白库 > MTNN_ECOLI
MTNN_ECOLI
ID   MTNN_ECOLI              Reviewed;         232 AA.
AC   P0AF12; P24247;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000303|PubMed:16101288};
DE            Short=MTA/SAH nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE            Short=MTAN {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000303|PubMed:16101288};
DE            EC=3.2.2.9 {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000269|PubMed:15911379, ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944};
DE   AltName: Full=5'-deoxyadenosine nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000305|PubMed:15911379};
DE            Short=DOA nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000305|PubMed:15911379};
DE            Short=dAdo nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000305|PubMed:15911379};
DE   AltName: Full=5'-methylthioadenosine nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE            Short=MTA nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE   AltName: Full=S-adenosylhomocysteine nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE            Short=AdoHcy nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE            Short=SAH nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
DE            Short=SRH nucleosidase {ECO:0000255|HAMAP-Rule:MF_01684};
GN   Name=mtnN {ECO:0000255|HAMAP-Rule:MF_01684}; Synonyms=mtn, pfs, yadA;
GN   OrderedLocusNames=b0159, JW0155;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=2157212; DOI=10.1073/pnas.87.7.2740;
RA   Wurgler S.M., Richardson C.C.;
RT   "Structure and regulation of the gene for dGTP triphosphohydrolase from
RT   Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2740-2744(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RX   PubMed=9524204; DOI=10.1016/s0167-4781(97)00169-3;
RA   Cornell K.A., Riscoe M.K.;
RT   "Cloning and expression of Escherichia coli 5'-methylthioadenosine/S-
RT   adenosylhomocysteine nucleosidase: identification of the pfs gene
RT   product.";
RL   Biochim. Biophys. Acta 1396:8-14(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=8202364; DOI=10.1093/nar/22.9.1637;
RA   Fujita N., Mori H., Yura T., Ishihama A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-
RT   4.1 min (110,917-193,643 bp) region.";
RL   Nucleic Acids Res. 22:1637-1639(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RA   Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M.,
RA   Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D.,
RA   Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.;
RT   "Sequence of minutes 4-25 of Escherichia coli.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND ACTIVITY REGULATION.
RX   PubMed=3911944; DOI=10.1042/bj2320335;
RA   Della Ragione F., Porcelli M., Carteni-Farina M., Zappia V., Pegg A.E.;
RT   "Escherichia coli S-adenosylhomocysteine/5'-methylthioadenosine
RT   nucleosidase. Purification, substrate specificity and mechanism of
RT   action.";
RL   Biochem. J. 232:335-341(1985).
RN   [8]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION.
RX   PubMed=8941345; DOI=10.1006/bbrc.1996.1723;
RA   Cornell K.A., Swarts W.E., Barry R.D., Riscoe M.K.;
RT   "Characterization of recombinant Eschericha coli 5'-methylthioadenosine/S-
RT   adenosylhomocysteine nucleosidase: analysis of enzymatic activity and
RT   substrate specificity.";
RL   Biochem. Biophys. Res. Commun. 228:724-732(1996).
RN   [9]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, KINETIC PARAMETERS, AND MUTAGENESIS OF MET-9;
RP   GLU-12; ILE-50; SER-76; PHE-151; MET-173; GLU-174; ARG-193; SER-196;
RP   ASP-197 AND PHE-207.
RX   PubMed=16101288; DOI=10.1021/bi050493q;
RA   Lee J.E., Luong W., Huang D.J., Cornell K.A., Riscoe M.K., Howell P.L.;
RT   "Mutational analysis of a nucleosidase involved in quorum-sensing
RT   autoinducer-2 biosynthesis.";
RL   Biochemistry 44:11049-11057(2005).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=15911379; DOI=10.1016/j.chembiol.2005.04.012;
RA   Choi-Rhee E., Cronan J.E.;
RT   "A nucleosidase required for in vivo function of the S-adenosyl-L-
RT   methionine radical enzyme, biotin synthase.";
RL   Chem. Biol. 12:589-593(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATE, AND
RP   SUBUNIT.
RX   PubMed=11591349; DOI=10.1016/s0969-2126(01)00656-6;
RA   Lee J.E., Cornell K.A., Riscoe M.K., Howell P.L.;
RT   "Structure of E. coli 5'-methylthioadenosine/S-adenosylhomocysteine
RT   nucleosidase reveals similarity to the purine nucleoside phosphorylases.";
RL   Structure 9:941-953(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOGS,
RP   AND ACTIVITY REGULATION.
RX   PubMed=12496243; DOI=10.1074/jbc.m210836200;
RA   Lee J.E., Cornell K.A., Riscoe M.K., Howell P.L.;
RT   "Structure of Escherichia coli 5'-methylthioadenosine/ S-
RT   adenosylhomocysteine nucleosidase inhibitor complexes provide insight into
RT   the conformational changes required for substrate binding and catalysis.";
RL   J. Biol. Chem. 278:8761-8770(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ANALOGS,
RP   AND ACTIVITY REGULATION.
RX   PubMed=15749708; DOI=10.1074/jbc.m414472200;
RA   Singh V., Evans G.B., Lenz D.H., Mason J.M., Clinch K., Mee S.,
RA   Painter G.F., Tyler P.C., Furneaux R.H., Lee J.E., Howell P.L.,
RA   Schramm V.L.;
RT   "Femtomolar transition state analogue inhibitors of 5'-
RT   methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia
RT   coli.";
RL   J. Biol. Chem. 280:18265-18273(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF WILD-TYPE AND MUTANTS ASN-197 AND
RP   GLN-12 IN COMPLEX WITH MTA SUBSTRATE OR PRODUCTS, REACTION MECHANISM, AND
RP   ACTIVE SITES.
RX   PubMed=16109423; DOI=10.1016/j.jmb.2005.07.027;
RA   Lee J.E., Smith G.D., Horvatin C., Huang D.J., Cornell K.A., Riscoe M.K.,
RA   Howell P.L.;
RT   "Structural snapshots of MTA/AdoHcy nucleosidase along the reaction
RT   coordinate provide insights into enzyme and nucleoside flexibility during
RT   catalysis.";
RL   J. Mol. Biol. 352:559-574(2005).
CC   -!- FUNCTION: Catalyzes the irreversible cleavage of the glycosidic bond in
CC       both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine
CC       (SAH/AdoHcy) to adenine and the corresponding thioribose, 5'-
CC       methylthioribose and S-ribosylhomocysteine, respectively
CC       (PubMed:3911944, PubMed:16101288). Also cleaves 5'-deoxyadenosine, a
CC       toxic by-product of radical S-adenosylmethionine (SAM) enzymes, into 5-
CC       deoxyribose and adenine. Thus, is required for in vivo function of the
CC       radical SAM enzymes biotin synthase and lipoic acid synthase, that are
CC       inhibited by 5'-deoxyadenosine accumulation (PubMed:15911379). Can also
CC       use 5'-isobutylthioadenosine, 5'-n-butylthioadenosine, S-adenosyl-D-
CC       homocysteine, decarboxylated adenosylhomocysteine, deaminated
CC       adenosylhomocysteine and S-2-aza-adenosylhomocysteine as substrates in
CC       vitro (PubMed:3911944). {ECO:0000269|PubMed:15911379,
CC       ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + S-adenosyl-L-homocysteine = adenine + S-(5-deoxy-D-
CC         ribos-5-yl)-L-homocysteine; Xref=Rhea:RHEA:17805, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16708, ChEBI:CHEBI:57856, ChEBI:CHEBI:58195; EC=3.2.2.9;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01684,
CC         ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + S-methyl-5'-thioadenosine = 5-(methylsulfanyl)-D-ribose
CC         + adenine; Xref=Rhea:RHEA:13617, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16708, ChEBI:CHEBI:17509, ChEBI:CHEBI:78440; EC=3.2.2.9;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01684,
CC         ECO:0000269|PubMed:16101288, ECO:0000269|PubMed:3911944};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-deoxyadenosine + H2O = 5-deoxy-D-ribose + adenine;
CC         Xref=Rhea:RHEA:29859, ChEBI:CHEBI:15377, ChEBI:CHEBI:16708,
CC         ChEBI:CHEBI:17319, ChEBI:CHEBI:149540; EC=3.2.2.9;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01684,
CC         ECO:0000269|PubMed:15911379};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29860;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01684,
CC         ECO:0000269|PubMed:15911379};
CC   -!- ACTIVITY REGULATION: Strongly inhibited by aryl-substituted MTA
CC       analogs, alkyl-substituted MTA analogs, 5'-methylthioformycin, 5'-
CC       chloroformycin, S-formycinylhomocysteine, 5'-methylthiotubercidin, S-
CC       tubercidinylhomocysteine and S-8-aza-adenosylhomocysteine. Poorly
CC       inhibited by 5'-isobutylthioinosine, 5'-n-butylthioinosine, 5'-
CC       methylthio-3-deaza-adenosine, 5'-isobutylthio-3-deaza-adenosine, S-n-6-
CC       methyl-3-deaza-adenosylhomocysteine, S-adenosylhomocysteine sulphoxide
CC       and Sinefungin. {ECO:0000269|PubMed:12496243,
CC       ECO:0000269|PubMed:15749708, ECO:0000269|PubMed:3911944,
CC       ECO:0000269|PubMed:8941345}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.4 uM for 5'-methylthioadenosine (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:3911944};
CC         KM=0.8 uM for 5'-methylthioadenosine (at pH 7 and 22 degrees Celsius)
CC         {ECO:0000269|PubMed:16101288};
CC         KM=4.3 uM for S-adenosylhomocysteine (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:3911944};
CC         KM=1.3 uM for S-adenosylhomocysteine (at pH 7 and 22 degrees Celsius)
CC         {ECO:0000269|PubMed:16101288};
CC         Note=kcat is 3.0 sec(-1) and 2.6 sec(-1) with 5'-methylthioadenosine
CC         and S-adenosylhomocysteine as substrate, respectively.
CC         {ECO:0000269|PubMed:16101288};
CC       pH dependence:
CC         Exhibits activity across a broad pH range. Enzyme activity is
CC         moderately improved under acidic conditions.
CC         {ECO:0000269|PubMed:8941345};
CC       Temperature dependence:
CC         Optimum temperature is 37-45 degrees Celsius. Rapidly inactivated
CC         after exposure for 10 minutes at 55 degrees Celsius.
CC         {ECO:0000269|PubMed:8941345};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage
CC       pathway; S-methyl-5-thio-alpha-D-ribose 1-phosphate from S-methyl-5'-
CC       thioadenosine (hydrolase route): step 1/2. {ECO:0000255|HAMAP-
CC       Rule:MF_01684}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01684,
CC       ECO:0000269|PubMed:11591349, ECO:0000269|PubMed:12496243,
CC       ECO:0000269|PubMed:15749708, ECO:0000269|PubMed:16109423}.
CC   -!- INTERACTION:
CC       P0AF12; P0AF12: mtnN; NbExp=2; IntAct=EBI-1114261, EBI-1114261;
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene are deficient in biotin
CC       synthase (BioB) activity in vivo due to accumulation of 5'-
CC       deoxyadenosine. {ECO:0000269|PubMed:15911379}.
CC   -!- SIMILARITY: Belongs to the PNP/UDP phosphorylase family. MtnN
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_01684, ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA23678.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M31772; AAA23678.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U24438; AAC38291.1; -; Genomic_DNA.
DR   EMBL; M83735; AAA24322.1; -; Genomic_DNA.
DR   EMBL; U70214; AAB08589.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73270.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAB96736.1; -; Genomic_DNA.
DR   PIR; S45227; S45227.
DR   RefSeq; NP_414701.1; NC_000913.3.
DR   RefSeq; WP_000689844.1; NZ_SSZK01000004.1.
DR   PDB; 1JYS; X-ray; 1.90 A; A/B=1-232.
DR   PDB; 1NC1; X-ray; 2.00 A; A/B=1-232.
DR   PDB; 1NC3; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Y6Q; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Y6R; X-ray; 2.20 A; A/B=1-232.
DR   PDB; 1Z5N; X-ray; 2.10 A; A/B=1-232.
DR   PDB; 1Z5O; X-ray; 2.00 A; A/B=1-232.
DR   PDB; 1Z5P; X-ray; 2.00 A; A=1-232.
DR   PDB; 3O4V; X-ray; 1.75 A; A/B=1-232.
DR   PDB; 4WKC; X-ray; 1.64 A; A=1-232.
DR   PDB; 4YML; X-ray; 1.75 A; A=1-232.
DR   PDBsum; 1JYS; -.
DR   PDBsum; 1NC1; -.
DR   PDBsum; 1NC3; -.
DR   PDBsum; 1Y6Q; -.
DR   PDBsum; 1Y6R; -.
DR   PDBsum; 1Z5N; -.
DR   PDBsum; 1Z5O; -.
DR   PDBsum; 1Z5P; -.
DR   PDBsum; 3O4V; -.
DR   PDBsum; 4WKC; -.
DR   PDBsum; 4YML; -.
DR   AlphaFoldDB; P0AF12; -.
DR   SMR; P0AF12; -.
DR   BioGRID; 4260991; 38.
DR   BioGRID; 852836; 1.
DR   DIP; DIP-10270N; -.
DR   IntAct; P0AF12; 7.
DR   STRING; 511145.b0159; -.
DR   BindingDB; P0AF12; -.
DR   DrugBank; DB02158; (2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol.
DR   DrugBank; DB08606; (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL.
DR   DrugBank; DB02933; 5'-Deoxy-5'-(Methylthio)-Tubercidin.
DR   DrugBank; DB00173; Adenine.
DR   DrugBank; DB02281; Formycin.
DR   SWISS-2DPAGE; P0AF12; -.
DR   jPOST; P0AF12; -.
DR   PaxDb; P0AF12; -.
DR   PRIDE; P0AF12; -.
DR   EnsemblBacteria; AAC73270; AAC73270; b0159.
DR   EnsemblBacteria; BAB96736; BAB96736; BAB96736.
DR   GeneID; 66671551; -.
DR   GeneID; 948542; -.
DR   KEGG; ecj:JW0155; -.
DR   KEGG; eco:b0159; -.
DR   PATRIC; fig|1411691.4.peg.2121; -.
DR   EchoBASE; EB1082; -.
DR   eggNOG; COG0775; Bacteria.
DR   HOGENOM; CLU_031248_2_2_6; -.
DR   InParanoid; P0AF12; -.
DR   OMA; DQFVHSK; -.
DR   PhylomeDB; P0AF12; -.
DR   BioCyc; EcoCyc:EG11090-MON; -.
DR   BioCyc; MetaCyc:EG11090-MON; -.
DR   BRENDA; 3.2.2.16; 2026.
DR   BRENDA; 3.2.2.30; 2026.
DR   BRENDA; 3.2.2.9; 2026.
DR   SABIO-RK; P0AF12; -.
DR   UniPathway; UPA00904; UER00871.
DR   EvolutionaryTrace; P0AF12; -.
DR   PRO; PR:P0AF12; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0008782; F:adenosylhomocysteine nucleosidase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008930; F:methylthioadenosine nucleosidase activity; IDA:EcoCyc.
DR   GO; GO:0019509; P:L-methionine salvage from methylthioadenosine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019284; P:L-methionine salvage from S-adenosylmethionine; IDA:EcoCyc.
DR   GO; GO:0046124; P:purine deoxyribonucleoside catabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0110052; P:toxic metabolite repair; IMP:UniProtKB.
DR   Gene3D; 3.40.50.1580; -; 1.
DR   HAMAP; MF_01684; Salvage_MtnN; 1.
DR   InterPro; IPR010049; MTA_SAH_Nsdase.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR035994; Nucleoside_phosphorylase_sf.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01704; MTA/SAH-Nsdase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Hydrolase; Methionine biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..232
FT                   /note="5'-methylthioadenosine/S-adenosylhomocysteine
FT                   nucleosidase"
FT                   /id="PRO_0000164439"
FT   ACT_SITE        12
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01684,
FT                   ECO:0000305|PubMed:16109423"
FT   ACT_SITE        197
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01684,
FT                   ECO:0000305|PubMed:16109423"
FT   BINDING         78
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01684,
FT                   ECO:0000269|PubMed:11591349"
FT   BINDING         152
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01684,
FT                   ECO:0000269|PubMed:11591349"
FT   BINDING         173..174
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01684"
FT   MUTAGEN         9
FT                   /note="M->A: 13-19% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         12
FT                   /note="E->A,Q: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         50
FT                   /note="I->A: 12-23% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         76
FT                   /note="S->A: 13-23% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         151
FT                   /note="F->A: 0.5% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         173
FT                   /note="M->A: 0.5% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         174
FT                   /note="E->A,Q: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         193
FT                   /note="R->A: 13-28% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         196
FT                   /note="S->A: 2-4% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         197
FT                   /note="D->A,N: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   MUTAGEN         207
FT                   /note="F->A: 2% of wild-type catalytic efficiency."
FT                   /evidence="ECO:0000269|PubMed:16101288"
FT   CONFLICT        212..232
FT                   /note="AVAAKQSSLMVESLVQKLAHG -> LLPLNSPA (in Ref. 1;
FT                   AAA23678/AAA24322)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..9
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           10..17
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          21..28
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          31..38
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          41..47
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           52..66
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          69..79
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          89..99
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          117..120
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           123..135
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          140..147
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           155..164
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           175..185
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   STRAND          189..197
FT                   /evidence="ECO:0007829|PDB:3O4V"
FT   HELIX           203..231
FT                   /evidence="ECO:0007829|PDB:3O4V"
SQ   SEQUENCE   232 AA;  24354 MW;  9B1FF9BEC39D4F2C CRC64;
     MKIGIIGAME EEVTLLRDKI ENRQTISLGG CEIYTGQLNG TEVALLKSGI GKVAAALGAT
     LLLEHCKPDV IINTGSAGGL APTLKVGDIV VSDEARYHDA DVTAFGYEYG QLPGCPAGFK
     ADDKLIAAAE ACIAELNLNA VRGLIVSGDA FINGSVGLAK IRHNFPQAIA VEMEATAIAH
     VCHNFNVPFV VVRAISDVAD QQSHLSFDEF LAVAAKQSSL MVESLVQKLA HG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024